眉间皱纹的临床试验
总计10000个结果
-
Rhizen Pharmaceuticals SAIncozen Therapeutics Pvt Ltd招聘中
-
Peter MacCallum Cancer Centre, Australia招聘中
-
Karolinska University Hospital终止
-
Novartis Pharmaceuticals终止
-
Shanghai Jiaolian Drug Research and Development...Shanghai Pharmaceuticals Holding Co., Ltd完全的
-
Istituto Scientifico Romagnolo per lo Studio e...Agenzia Italiana del Farmaco完全的
-
Calithera Biosciences, Inc完全的
-
Veru Inc.撤销
-
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.未知
-
City of Hope Medical Center完全的乳腺癌 | I期乳腺癌 | II期乳腺癌 | IIIA期乳腺癌 | IIIB期乳腺癌 | IIIC期乳腺癌 | 乳腺导管原位癌美国
-
University of WashingtonKuni Foundation招聘中
-
Mayo Clinic招聘中
-
Memorial Sloan Kettering Cancer Center撤销乳腺癌 | 转移性乳腺癌 | 乳腺癌 | 转移性乳腺癌 | 女性乳腺癌
-
Kristina A. FanucciJohns Hopkins University; Translational Breast Cancer Research Consortium; Menarini Group; Stemline...招聘中乳腺癌 | 乳腺肿瘤 | 转移性乳腺癌 | 人类表皮生长因子 2 阴性乳腺癌 | 雌激素受体阳性乳腺癌 | ESR1基因突变 | 激素受体阳性乳腺癌 | HER2-乳腺癌 | ER野生型美国
-
Memorial Sloan Kettering Cancer Center完全的
-
H. Lee Moffitt Cancer Center and Research InstituteNational Cancer Institute (NCI)完全的
-
National Cancer Institute (NCI)NRG Oncology终止不可切除的乳腺癌 | IV 期乳腺癌 AJCC v6 和 v7 | III 期乳腺癌 AJCC v7 | 转移性乳腺癌 | 转移性 HER2 阳性乳腺癌 | 复发性乳腺癌 | 复发性 HER2 阳性乳腺癌 | 不可切除的 HER2 阳性乳腺癌美国, 加拿大
-
Ohio State University Comprehensive Cancer CenterNational Cancer Institute (NCI)完全的IIIA期乳腺癌 | IIIB期乳腺癌 | IA期乳腺癌 | IB 期乳腺癌 | IIA期乳腺癌 | IIB期乳腺癌 | IIIC期乳腺癌 | HER2/Neu 阴性 | 雌激素受体和/或孕激素受体阳性美国
-
Avelas Biosciences, Inc.Clinipace Worldwide; RRD International, Inc.完全的I期乳腺癌 | II期乳腺癌 | 癌，导管，乳腺癌 | 乳腺癌女性 | III期乳腺癌 | 乳腺癌 | 女性乳腺原发性浸润性恶性肿瘤美国
-
Ohio State University Comprehensive Cancer CenterAmerican Institute for Cancer Research招聘中
-
University of WashingtonNational Cancer Institute (NCI)完全的
-
Universitas Airlangga尚未招聘乳腺癌 | 女性乳腺肿瘤 | 局部晚期乳腺癌 | 局部晚期乳腺癌 (LABC)
-
Peking University People's Hospital尚未招聘HER2 阴性乳腺癌 | 激素受体阳性乳腺癌 | 早期乳腺癌 | ctDNA监测 | 高危乳腺癌
-
Cancer Institute and Hospital, Chinese Academy...尚未招聘
-
Ana C Garrido-Castro, MDAstraZeneca; Translational Breast Cancer Research Consortium招聘中
-
Kathy MillerPfizer; Astex Pharmaceuticals, Inc.; Van Andel Institute Stand Up to Cancer Team完全的
-
CytomX Therapeutics完全的肿瘤 | 乳腺癌 | 乳腺肿瘤 | 乳腺肿瘤，三阴性 | 乳腺肿瘤，激素受体阳性/HER2 阴性美国, 西班牙, 大韩民国
-
University of Southern CaliforniaNational Cancer Institute (NCI)终止
-
Mayo ClinicNational Cancer Institute (NCI)终止解剖学 I 期乳腺癌 AJCC v8 | 解剖学 IA 期乳腺癌 AJCC v8 | 解剖学 IB 期乳腺癌 AJCC v8 | 解剖学 II 期乳腺癌 AJCC v8 | 解剖学 IIA 期乳腺癌 AJCC v8 | 解剖学 IIB 期乳腺癌 AJCC v8 | 解剖学 III 期乳腺癌 AJCC v8 | 解剖学 IIIA 期乳腺癌 AJCC v8 | 解剖学 IIIB 期乳腺癌 AJCC v8 | 解剖学 IIIC 期乳腺癌 AJCC v8 | 预后 I 期乳腺癌 AJCC v8 | 预后 IA 期乳腺癌 AJCC v8 | 预后 IB 期乳腺癌 AJCC v8 | 预后 II 期乳腺癌 AJCC v8 | 预后 IIA 期乳腺癌 AJCC v8 | 预后... 及其他条件美国
-
Federico II University尚未招聘乳腺癌 | 转移性乳腺癌 | HER2 阴性乳腺癌
-
Washington University School of MedicinePfizer; Rising Tide Foundation终止